ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models

por Yeom, Dong-Hoon, Lee, Yo-Seob, Ryu, Ilhwan, Lee, Sunju, Sung, Byungje, Lee, Han-Byul, Kim, Dongin, Ahn, Jin-Hyung, Ha, Eunsin, Choi, Yong-Soo, Lee, Sang Hoon, You, Weon-Kyoo
Publicado 2020

Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer

por Kim, Da-Hyun, Lee, Seul, Kang, Hyeok Gu, Park, Hyun-Woo, Lee, Han-Woong, Kim, Dongin, Yoem, Dong-Hoon, Ahn, Jin-Hyung, Ha, Eunsin, You, Weon-Kyoo, Lee, Sang Hoon, Kim, Seok-Jun, Chun, Kyung-Hee
Publicado 2020